These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22325807)

  • 1. Staff-patient relationships and outcomes in schizophrenia: the role of staff attributions.
    Berry K; Gregg L; Vasconcelos e Sa D; Haddock G; Barrowclough C
    Behav Res Ther; 2012 Mar; 50(3):210-4. PubMed ID: 22325807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.
    Haddock G; Barrowclough C; Tarrier N; Moring J; O'Brien R; Schofield N; Quinn J; Palmer S; Davies L; Lowens I; McGovern J; Lewis S
    Br J Psychiatry; 2003 Nov; 183():418-26. PubMed ID: 14594917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of expressed emotion in relationships between psychiatric staff and people with a diagnosis of psychosis: a review of the literature.
    Berry K; Barrowclough C; Haddock G
    Schizophr Bull; 2011 Sep; 37(5):958-72. PubMed ID: 20056685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.
    Barrowclough C; Haddock G; Wykes T; Beardmore R; Conrod P; Craig T; Davies L; Dunn G; Eisner E; Lewis S; Moring J; Steel C; Tarrier N
    BMJ; 2010 Nov; 341():c6325. PubMed ID: 21106618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophrenia.
    Wittorf A; Jakobi U; Bechdolf A; Müller B; Sartory G; Wagner M; Wiedemann G; Wölwer W; Herrlich J; Buchkremer G; Klingberg S
    Eur Psychiatry; 2009 May; 24(4):259-67. PubMed ID: 19200695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-resistant schizophrenia and staff rejection.
    Heresco-Levy U; Ermilov M; Giltsinsky B; Lichtenstein M; Blander D
    Schizophr Bull; 1999; 25(3):457-65. PubMed ID: 10478781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staff attachment styles: a pilot study investigating the influence of adult attachment styles on staff psychological mindedness and therapeutic relationships.
    Berry K; Shah R; Cook A; Geater E; Barrowclough C; Wearden A
    J Clin Psychol; 2008 Mar; 64(3):355-63. PubMed ID: 18302212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch, a new intervention that targets motivational negative symptoms in people with schizophrenia: An uncontrolled pilot study.
    Thonon B; Levaux MN; Della Libera C; Larøi F
    J Clin Psychol; 2020 Oct; 76(10):1797-1806. PubMed ID: 32453892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting therapeutic alliance in clients with psychosis and substance misuse.
    Barrowclough C; Meier P; Beardmore R; Emsley R
    J Nerv Ment Dis; 2010 May; 198(5):373-7. PubMed ID: 20458201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staff expressed emotion and causal attributions for client problems on a low security unit: an exploratory study.
    Barrowclough C; Haddock G; Lowens I; Connor A; Pidliswyj J; Tracey N
    Schizophr Bull; 2001; 27(3):517-26. PubMed ID: 11596852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of motivation for treatment success.
    Medalia A; Saperstein A
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S122-8. PubMed ID: 21860041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social disinterest attitudes and group cognitive-behavioral social skills training for functional disability in schizophrenia.
    Granholm E; Ben-Zeev D; Link PC
    Schizophr Bull; 2009 Sep; 35(5):874-83. PubMed ID: 19628761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial].
    Bechdolf A; Pohlmann B; Güttgemanns J; Geyer C; Lindner K; Ferber C; Gouzoulis-Mayfrank E
    Nervenarzt; 2012 Jul; 83(7):888-96. PubMed ID: 21720841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of agitation in patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 2008 Jun; 69(6):e17. PubMed ID: 18683992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study investigating the use of psychological formulations to modify psychiatric staff perceptions of service users with psychosis.
    Berry K; Barrowclough C; Wearden A
    Behav Cogn Psychother; 2009 Jan; 37(1):39-48. PubMed ID: 19364406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia.
    Velligan DI; Diamond PM; Maples NJ; Mintz J; Li X; Glahn DC; Miller AL
    Schizophr Res; 2008 Jul; 102(1-3):312-9. PubMed ID: 18374542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive memory training for the treatment of depression in schizophrenia: A randomised controlled trial.
    Steel C; Korrelboom K; Fazil Baksh M; Kingdon D; Simon J; Wykes T; Phiri P; van der Gaag M
    Behav Res Ther; 2020 Dec; 135():103734. PubMed ID: 33002684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in Negative Symptoms and Functioning in Cognitive-Behavioral Social Skills Training for Schizophrenia: Mediation by Defeatist Performance Attitudes and Asocial Beliefs.
    Granholm E; Holden J; Worley M
    Schizophr Bull; 2018 Apr; 44(3):653-661. PubMed ID: 29036391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of cognitive-motivational therapy program (PIPE) for the initial phase of schizophrenia: Maintenance of efficacy at 5-year follow up
    Palma C; Farriols N; Frías A; Cañete J; Gomis O; Fernández M; Alonso I; Signo S
    Psychiatry Res; 2019 Mar; 273():586-594. PubMed ID: 30716598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.